» Articles » PMID: 16809784

Constitutive ALK5-independent C-Jun N-terminal Kinase Activation Contributes to Endothelin-1 Overexpression in Pulmonary Fibrosis: Evidence of an Autocrine Endothelin Loop Operating Through the Endothelin A and B Receptors

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2006 Jul 1
PMID 16809784
Citations 73
Authors
Affiliations
Soon will be listed here.
Abstract

The signal transduction mechanisms generating pathological fibrosis are almost wholly unknown. Endothelin-1 (ET-1), which is up-regulated during tissue repair and fibrosis, induces lung fibroblasts to produce and contract extracellular matrix. Lung fibroblasts isolated from scleroderma patients with chronic pulmonary fibrosis produce elevated levels of ET-1, which contribute to the persistent fibrotic phenotype of these cells. Transforming growth factor beta (TGF-beta) induces fibroblasts to produce and contract matrix. In this report, we show that TGF-beta induces ET-1 in normal and fibrotic lung fibroblasts in a Smad-independent ALK5/c-Jun N-terminal kinase (JNK)/Ap-1-dependent fashion. ET-1 induces JNK through TAK1. Fibrotic lung fibroblasts display constitutive JNK activation, which was reduced by the dual ETA/ETB receptor inhibitor, bosentan, providing evidence of an autocrine endothelin loop. Thus, ET-1 and TGF-beta are likely to cooperate in the pathogenesis of pulmonary fibrosis. As elevated JNK activation in fibrotic lung fibroblasts contributes to the persistence of the myofibroblast phenotype in pulmonary fibrosis by promoting an autocrine ET-1 loop, targeting the ETA and ETB receptors or constitutive JNK activation by fibrotic lung fibroblasts is likely to be of benefit in combating chronic pulmonary fibrosis.

Citing Articles

Aspirin Caused Intestinal Damage through FXR and ET-1 Signaling Pathways.

Lin Q, Zhang B, Dai M, Cheng Y, Li F Int J Mol Sci. 2024; 25(6).

PMID: 38542397 PMC: 10970274. DOI: 10.3390/ijms25063424.


The Pathogenesis of Systemic Sclerosis: The Origin of Fibrosis and Interlink with Vasculopathy and Autoimmunity.

Ko J, Noviani M, Chellamuthu V, Albani S, Low A Int J Mol Sci. 2023; 24(18).

PMID: 37762589 PMC: 10532389. DOI: 10.3390/ijms241814287.


Dual Blockade of TGF-β Receptor and Endothelin Receptor Synergistically Inhibits Angiotensin II-Induced Myofibroblast Differentiation: Role of ATR/G-Mediated TGF-β1 and ET-1 Signaling.

Duangrat R, Parichatikanond W, Mangmool S Int J Mol Sci. 2023; 24(8).

PMID: 37108136 PMC: 10138810. DOI: 10.3390/ijms24086972.


Profibrotic Effects of Endothelin-1 on Fibroblasts Are Mediated by Aldosterone in Vitro: Relevance to the Pathogenesis and Therapy of Systemic Sclerosis and Pulmonary Arterial Hypertension.

Argentino G, Barbieri A, Beri R, Bason C, Ruzzenente A, Olivieri O Biomedicines. 2022; 10(11).

PMID: 36359285 PMC: 9687242. DOI: 10.3390/biomedicines10112765.


Safety, Pharmacokinetics, and Pharmacodynamics of CC-90001 (BMS-986360), a c-Jun N-terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants.

Ye Y, Gaudy A, Thomas M, Reyes J, Burkhardt B, Horan G Clin Pharmacol Drug Dev. 2022; 11(12):1394-1404.

PMID: 36256505 PMC: 10092235. DOI: 10.1002/cpdd.1178.


References
1.
Hashimoto S, Gon Y, Takeshita I, Matsumoto K, Maruoka S, Horie T . Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway. Am J Respir Crit Care Med. 2001; 163(1):152-7. DOI: 10.1164/ajrccm.163.1.2005069. View

2.
Chen Y, Shi-Wen X, Eastwood M, Black C, Denton C, Leask A . Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum. 2006; 54(4):1309-16. DOI: 10.1002/art.21725. View

3.
Holmes A, Abraham D, Sa S, Shiwen X, Black C, Leask A . CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem. 2001; 276(14):10594-601. DOI: 10.1074/jbc.M010149200. View

4.
Piek E, Ju W, HEYER J, Escalante-Alcalde D, Stewart C, Weinstein M . Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem. 2001; 276(23):19945-53. DOI: 10.1074/jbc.M102382200. View

5.
Coker R, Laurent G, Jeffery P, du Bois R, Black C, McAnulty R . Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax. 2001; 56(7):549-56. PMC: 1746092. DOI: 10.1136/thorax.56.7.549. View